Bristol-Myer Squibb says it will seek FDA approval for ipilimumab as a second-line treatment in advanced melanoma in 2010.Melanoma..Jim Breitfeller

Bristol-Myer Squibb says it will seek FDA approval for ipilimumab as a second-line treatment in advanced melanoma in 2010.

"Phase 3 top-line results are due from a study of ipilimumab in patients with previously untreated metastatic melanoma taking a combination of ipilimumab plus the chemotherapy dacarbazine or dacarbazine plus placebo. Concurrent with a business update to analysts and investors on Mar. 4, BMS says it will seek U.S. regulatory approval for ipilimumab as a second-line treatment in advanced melanoma in 2010, and will move the drug into Phase 3 trials in non-small cell lung cancer based on Phase 2 study data, which it would present at a major medical meeting later in 2010. The company did not provide any additional details on the data."

Source:










Bristol-Myer Squibb's Ipilimumab Can't Cure Cancer alone, It will need to be done with Combinatorial Therapy.









Take Care,

Jimmy B